Know Labs Inc (KNW)

[tim00mike]

Thanks for thoughts; FYI, Without FDA approval, P. Bosua, will be leaving A LOT on the table; as he is scheduled to receive 1.2 million shares of Know common stock on UBAND FDA approval.

Form 10-Q June 30, 2020

On November 4, 2019, the Company granted a stock option grant to Philip A. Bosua for 1,200,000 shares with an exercise price of $1.10 per share. The performance grant expires November 4, 2024 and vests upon FDA approval of the UBAND blood glucose monitor.